Contact

Request Information

Please complete the form below, and an admissions advisor will contact you shortly.

800-628-8648

Apply Now

Ready to take the next step?

The application process is easy. We accept and review applications year-round, and qualified applicants can begin classes any month of the year, depending on your program and location.

Click Apply Now to get started on the next exciting chapter of your life!

Apply Now

RTT 317 Clinical Concepts III

Course Description

Current principle and practice of treatment for cancers of the genitourinary, lymphoreticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers are emphasized.

Learning Outcomes

  • Given a clinical scenario determine the most effective overall treatment plan for cancers of the genitourinary, lymphoreticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers.
  • Determine the most appropriate beam modifiers, immobilization devices and set-up devices to use for cancers of the geitourinary, lyphoreticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers given cancer stage, histology, and grade.
  • Determine the most appropriate beam energy doses for cancers of the genitourinary, lymphoereticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers given a cancer stage, histology, and grade.
  • Determine the most appropriate treatment techniques and modlaieties for cancers of the genitourinary, lymphoreticular, musculoskeletal, integumentary, hemtopoietic, endocrine systems and pediatric cancers. Analyze a given cancer state, histology, and grade.
  • Analyze port films to determine the area being treated and the techniques used.
  • Using the natural history of a particular cancer, determine what structures the treatment field should contain for cancers of the genitourinary, lymphoreticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers.
  • Evaluate a given treatment plan to determine appropriateness based on cancer type, stage and grade for cancers of the genitourinary, lymphoreticular, musculoskeletal, integumentary, hematopoietic, endocrine systems and pediatric cancers.